• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gb Sciences Inc (OP:GBLX)

0.0005 UNCHANGED
Streaming Delayed Price Updated: 9:30 AM EST, Jan 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 115
Open 0.0005
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0005
Today's Range 0.0005 - 0.0005
52wk Range 0.0001 - 0.0085
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Cannabis On Thanksgiving: 10 Science-Backed Benefits For A Happier Holiday ↗
November 27, 2024
Discover 10 science-backed cannabis benefits for Thanksgiving, from reducing stress to boosting appetite, mood, and sleep quality. 
Via Benzinga
Topics Cannabis
News headline image
GB Sciences Signs Letter of Intent for a License to Develop and Market Their Cannabinoid-Based Parkinson’s Formulation With Endopure Life Sciences
July 02, 2024
Via ACCESSWIRE

Performance

YTD
N/A
N/A
1 Month
+25.0%
+25.0%
3 Month
+150.0%
+150.0%
6 Month
+150.0%
+150.0%
1 Year
-85.7%
-85.7%

More News

Read More
News headline image
Gb Sciences’ Novel Parkinson’s Disease Medication is Featured on Worldwide Business with kathy ireland(R)
December 14, 2023
Via ACCESSWIRE
News headline image
Gb Sciences' First-in-Class Parkinson's Disease Therapy Successfully Completes Dose Response Study at the University of Lethbridge
July 11, 2023
Via ACCESSWIRE
News headline image
GB Sciences' First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson's Disease Has Been Issued in China
March 20, 2023
Via ACCESSWIRE
News headline image
Successful 2022 Milestones Support Value of Gb Sciences' AI-Enabled Drug Discovery Platform
March 07, 2023
Via ACCESSWIRE
News headline image
Marijuana And Chronic Pain: Gb Sciences' Nanoparticle Technology Boosts Efficacy Of Cannabis Terpenes ↗
March 29, 2022
Via Benzinga
News headline image
Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform
December 22, 2022
Via Newswire.com
Topics Death
News headline image
Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform
December 22, 2022
From Gb Sciences
Via GlobeNewswire
News headline image
Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations
December 12, 2022
Via Newswire.com
News headline image
Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations
December 12, 2022
From Gb Sciences
Via GlobeNewswire
News headline image
Cannabis Terpenes Reduce Inflammation, Says Gb Sciences Study ↗
November 01, 2022
Via Benzinga
News headline image
Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredients
November 01, 2022
Via Newswire.com
Topics Cannabis
News headline image
Gb Sciences' Plant-based Formulations Designed to Treat Anxiety Achieve Statistical Significance in Animal Study
October 24, 2022
Via Newswire.com
News headline image
TODAY: Gb Sciences' President Demonstrates Effectiveness of Simplified Therapeutic Mixtures Inspired by Cannabis Plant Extracts at Canna Pharma 2022 Conference
October 13, 2022
Via Newswire.com
Topics Cannabis
News headline image
New Study Shows Promising Results In Treatment Of Parkinson's Disease With Cannabinoids ↗
October 10, 2022
Via Benzinga
News headline image
Gb Sciences Co-Publishes Study Demonstrating Efficacy of Its Proprietary Cannabinoid Mixtures for the Treatment of Parkinson's Disease
October 10, 2022
Via Newswire.com
Topics Cannabis
News headline image
TODAY: Gb Sciences Describes Drug Development Progress in Pharma's Almanac Journal Article
September 06, 2022
Via Newswire.com
Topics Cannabis
News headline image
TODAY: Gb Sciences' President and Chief Science Officer Presents Keynote Address on Cannabinoid-Containing Formulations for Parkinson's Disease at 2022 NeuroForum Summit
May 23, 2022
Via Newswire.com
Topics Intellectual Property
News headline image
TODAY: Gb Sciences Showcases Its PhAROS™ Drug Discovery Platform at the 2nd ALCOR Drug Discovery Platform Summit
May 12, 2022
Via Newswire.com
Topics Intellectual Property
News headline image
TODAY: Gb Sciences' Novel Plant-Inspired Pain Medications Featured at SMi's 22nd Annual Pain Therapeutics Conference
May 05, 2022
Via Newswire.com
News headline image
FHI Clinical to Write Clinical Trial Protocol for Development of Gb Sciences' COVID-19-Related, Anti-Inflammatory Therapies
May 02, 2022
Via Newswire.com
News headline image
Gb Sciences To Begin Dosage Study For Cannabinoid-Containing Drug For Treatment Of Parkinson's Disease ↗
April 12, 2022
Via Benzinga
News headline image
Gb Sciences to Begin Dosage Study for Its Novel Parkinson's Disease Formulations at the University of Lethbridge
April 12, 2022
Via Newswire.com
Topics Intellectual Property
News headline image
Gb Sciences' Nanoparticle Encapsulation Technology Improves the Efficacy of Terpenes for Use in Our Chronic Pain Formulations as Demonstrated in New Research Article
March 29, 2022
Via Newswire.com

Frequently Asked Questions

Is Gb Sciences Inc publicly traded?
Yes, Gb Sciences Inc is publicly traded.
What exchange does Gb Sciences Inc trade on?
Gb Sciences Inc trades on the OTC Traded
What is the ticker symbol for Gb Sciences Inc?
The ticker symbol for Gb Sciences Inc is GBLX on the OTC Traded
What is the current price of Gb Sciences Inc?
The current price of Gb Sciences Inc is 0.0005
When was Gb Sciences Inc last traded?
The last trade of Gb Sciences Inc was at 01/06/26 09:30 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap